Edesa Biotech Inc (EDSA) - News Archive

Showing 2 of 2 results.

Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Edesa Biotech Raises $15 Million in Private Placement to Advance Immuno-Inflammatory TherapiesEdesa Biotech, Inc. (Nasdaq: EDSA), a Toronto-based clinical-stage biopharmaceutical company, is making significant strides i...

Feb 13, 2025 • Major Pharmaceutical Preparations Industry Shares Vitiligo

Edesa Biotech Drives Innovation with $5 Million Investment Toward Breakthrough Immune Therapies,

In a strategic move poised to fortify its financial foundation and advance its pioneering therapeutic developments, Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage biopharmaceutical firm renowned for its cutting-ed...

Oct 31, 2024 • Major Pharmaceutical Preparations Industry Shares